Shares of Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 182.05 ($2.40) and traded as high as GBX 221 ($2.92). Faron Pharmaceuticals Oy shares last traded at GBX 215 ($2.84), with a volume of 2,900 shares trading hands.
Faron Pharmaceuticals Oy Price Performance
The firm has a market cap of £224.93 million, a P/E ratio of -671.88 and a beta of 0.36. The company’s 50-day moving average is GBX 182.05 and its two-hundred day moving average is GBX 154.47. The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09.
Faron Pharmaceuticals Oy Company Profile
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.
Further Reading
- Five stocks we like better than Faron Pharmaceuticals Oy
- How to Invest in the FAANG Stocks
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- What Are Dividend Challengers?
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
